Related Experiment Videos

[Aorto-coronary bypass grafting in a patient with neutrocytopenia]

Insights

Corticosteroid therapy effectively managed neutrocytopenia in a patient undergoing coronary artery bypass surgery. This treatment normalized leukocyte counts, ensuring a stable recovery and predicting a favorable hematological response to surgical stress.

Area of Science:

  • Cardiology
  • Hematology
  • Pharmacology

Background:

  • Neutrocytopenia, a condition characterized by low white blood cell counts, poses a significant risk for patients undergoing major surgical procedures.
  • Pre-operative management of neutrocytopenia is crucial to mitigate surgical complications, particularly infections.
  • Corticosteroids are known to influence leukocyte counts and immune function.

Observation:

  • A 71-year-old female patient presented with neutrocytopenia (690/mm3) prior to scheduled coronary artery bypass grafting.
  • The patient received prednisolone as a therapeutic intervention for neutrocytopenia.
  • Following prednisolone treatment, the patient's hemogram normalized with a significant increase in leukocyte counts.

Findings:

  • Aorto-coronary bypass grafting using a saphenous vein graft was successfully performed for left main trunk disease.
  • The patient experienced a stable convalescence post-surgery.
  • No infectious or adrenal complications were observed during the post-operative period.

Implications:

  • Corticosteroid therapy can be a valuable strategy for managing neutrocytopenia in patients scheduled for major cardiovascular surgery.
  • Pre-operative hematological normalization through steroid treatment may predict a favorable response to surgical stress.
  • This case highlights the potential role of steroids in optimizing patient condition for complex cardiac procedures, reducing perioperative risks.

Related Concept Videos